All In Biotech

Free tool

FAERS Monitor: Thiola

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019569 or its brand name (Thiola, Tiopronin). Reports on generic versions are filed under their own applications.

Reports

1,772

Serious

332

19% of reports

Hospitalization

213

Death reported

59

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective502
  • drug dose omission257
  • nausea150
  • pain108
  • pyrexia83
  • rash83
  • nephrolithiasis82
  • fatigue71
  • arthralgia70
  • vomiting67
  • pruritus64
  • diarrhoea58
  • headache58
  • abdominal discomfort47
  • rash generalised42

Reports by year received

View as table
YearReports
20043
20056
20061
20074
20085
20092
20108
201136
201237
20138
20143
2015158
2016329
2017592
2018279
201946
202021
202119
202246
202328
202444
202565
202632

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,387 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nephrolithiasisSignal8221.317.21,563
rash generalisedSignal4219.314.3710
drug dose omissionSignal25718.516.54,259
drug ineffectiveSignal5024.54.21,465
abdominal discomfortSignal473.32.575
pyrexiaSignal832.82.399
rashSignal832.31.858
nauseaSignal1502.21.9107
painSignal1082.11.762
arthralgia702.01.635
pruritus642.01.630
vomiting671.71.319
headache581.10.90
fatigue711.10.90
diarrhoea581.10.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.